Montelukast Prescribing at SKERNE MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,311
Total Quantity
58.0K
NHS Cost
£2.8K
vs National Avg
+237.5%
SKERNE MEDICAL GROUP prescribed 2,311 items of Montelukast over the last 12 months at a cost of £2,834 to the NHS. This is 237.5% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
178
Jul 2026
194
Jul 2026
201
Jul 2026
173
Jul 2026
196
Jul 2026
186
Jul 2026
206
Jul 2026
179
Jul 2026
197
Jul 2026
175
Jul 2026
220
Jul 2026
206
Prescribing Details
| Total Items | 2,311 |
|---|---|
| Total Quantity | 57,968 |
| Total NHS Cost | £2,834 |
| Presentations | 4 different forms |
| vs National Average | +237.5% |
Montelukast Prescribing Comparison
| This practice | 2,311 items |
|---|---|
| National average per practice | 685 items |
| Difference | +237.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.